Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Aug;54(2):331–335. doi: 10.1038/bjc.1986.181

Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.

M M Nauta, E Boven, H M Schlüper, C A Erkelens, H M Pinedo
PMCID: PMC2001520  PMID: 3017398

Full text

PDF
331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagley C. M., Jr, Bostick F. W., DeVita V. T., Jr Clinical pharmacology of cyclophosphamide. Cancer Res. 1973 Feb;33(2):226–233. [PubMed] [Google Scholar]
  2. Boven E., Nauta M. M., Schluper H. M., Elferink F., van der Vijgh W. J., Pinedo H. M. Secondary screening of platinum compounds in human ovarian cancer xenografts in nude mice. Eur J Cancer Clin Oncol. 1985 Oct;21(10):1253–1260. doi: 10.1016/0277-5379(85)90023-9. [DOI] [PubMed] [Google Scholar]
  3. Boven E., van der Vijgh W. J., Nauta M. M., Schlüper H. M., Pinedo H. M. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts. Cancer Res. 1985 Jan;45(1):86–90. [PubMed] [Google Scholar]
  4. Fodstad O., Hansen C. T., Cannon G. B., Statham C. N., Lichtenstein G. R., Boyd M. R. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects. Cancer Res. 1984 Oct;44(10):4403–4408. [PubMed] [Google Scholar]
  5. Fogh J., Tiso J., Orfeo T., Sharkey F. E., Daniels W. P., Fogh J. M. Thirty-four lines of six human tumor categories established in nude mice. J Natl Cancer Inst. 1980 Apr;64(4):745–751. [PubMed] [Google Scholar]
  6. Friedlander M. L., Russell P., Taylor I. W., Tattersall M. H. Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer. Br J Cancer. 1985 Mar;51(3):319–333. doi: 10.1038/bjc.1985.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giovanella B. C., Stehlin J. S., Jr, Williams L. J., Jr, Lee S. S., Shepard R. C. Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy. Cancer. 1978 Nov;42(5):2269–2281. doi: 10.1002/1097-0142(197811)42:5<2269::aid-cncr2820420527>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  8. Hanna N., Davis T. W., Fidler I. J. Environmental and genetic factors determine the level of NK activity of nude mice and affect their suitability as models for experimental metastasis. Int J Cancer. 1982 Sep 15;30(3):371–376. doi: 10.1002/ijc.2910300319. [DOI] [PubMed] [Google Scholar]
  9. Hanna N., Fidler I. J. Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst. 1980 Oct;65(4):801–809. doi: 10.1093/jnci/65.4.801. [DOI] [PubMed] [Google Scholar]
  10. Herberman R. B., Nunn M. E., Lavrin D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer. 1975 Aug 15;16(2):216–229. doi: 10.1002/ijc.2910160204. [DOI] [PubMed] [Google Scholar]
  11. Hunninghake G. W., Fauci A. S. Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities. J Immunol. 1976 Jul;117(1):337–342. [PubMed] [Google Scholar]
  12. Kopper L., Van Hanh T., Hegedüs C., Lapis K. Growth of human colorectal tumor xenografts in immunosuppressed mice reconstituted with normal cells. Exp Cell Biol. 1981;49(3):141–147. doi: 10.1159/000163816. [DOI] [PubMed] [Google Scholar]
  13. Kopper L., Van Hanh T., Lapis K., Timár J. Increased take rate of human tumour xenografts after carragheenan treatment. Eur J Cancer. 1980 May;16(5):671–678. doi: 10.1016/0014-2964(80)90208-x. [DOI] [PubMed] [Google Scholar]
  14. Kullander S., Rausing A., Tropé C. Human ovarian tumours heterotransplanted to "nude" mice. Acta Obstet Gynecol Scand. 1978;57(2):149–159. doi: 10.3109/00016347809155895. [DOI] [PubMed] [Google Scholar]
  15. Kyriazis A. A., Kyriazis A. P. Preferential sites of growth of human tumors in nude mice following subcutaneous transplantation. Cancer Res. 1980 Dec;40(12):4509–4511. [PubMed] [Google Scholar]
  16. Leung C. K., Shiu R. P. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice. Cancer Res. 1981 Feb;41(2):546–551. [PubMed] [Google Scholar]
  17. Maruo K., Ueyama Y., Hioki K., Saito M., Nomura T., Tamaoki N. Strain-dependent growth of a human carcinoma in nude mice with different genetic backgrounds: selection of nude mouse strains useful for anticancer agent screening system. Exp Cell Biol. 1982;50(2):115–119. doi: 10.1159/000163136. [DOI] [PubMed] [Google Scholar]
  18. Riccardi C., Barlozzari T., Santoni A., Herberman R. B., Cesarini C. Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors. J Immunol. 1981 Apr;126(4):1284–1289. [PubMed] [Google Scholar]
  19. Romijn J. C. Growth of tumor cells with different sensitivities for murine natural killer cells in young and adult athymic nude mice. Exp Cell Biol. 1985;53(1):24–31. doi: 10.1159/000163292. [DOI] [PubMed] [Google Scholar]
  20. Sharp A. K., Colston M. J. The regulation of macrophage activity in congenitally athymic mice. Eur J Immunol. 1984 Jan;14(1):102–105. doi: 10.1002/eji.1830140119. [DOI] [PubMed] [Google Scholar]
  21. Talmadge J. E., Meyers K. M., Prieur D. J., Starkey J. R. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice. J Natl Cancer Inst. 1980 Nov;65(5):929–935. [PubMed] [Google Scholar]
  22. Vetvicka V., Fornůsek L., Holub M., Zídková J., Kopecek J. Macrophages of athymic nude mice: Fc receptors, C receptors, phagocytic and pinocytic activities. Eur J Cell Biol. 1984 Sep;35(1):35–40. [PubMed] [Google Scholar]
  23. Vollmer T. L., Conley F. K. Effect of cyclophosphamide on survival of mice and incidence of metastatic tumor following intravenous and intracardial inoculation of tumor cells. Cancer Res. 1984 Sep;44(9):3902–3906. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES